Industry is adapting to the increasing complexity and poor solubility and bioavailability of molecules in the pipeline. Poor solubility and low bioavailability have hindered the development pipeline ...

Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges. Increasingly, ...

Representation of three different types of platforms for ionic liquid-based drug development to deliver poorly soluble compounds--Courtesy of Russian Academy of Sciences A new way to develop drugs may ...

Flavour compounds with a low solubility may form complexes with high-amylose maize starch, offering innovative encapsulation and cost-saving benefits, says a new study. Researchers from Kasetsart ...